News

FYR Diagnostics, Texas A&M University, and University of New Mexico awarded NIH grant for early detection of Neonatal Opioid Withdrawal Syndrome (NOWS)

MISSOULA, MONTANA, August 31, 2022 – Newborns develop Neonatal Opioid Withdrawal Syndrome (NOWS) when the mother is exposed to opioids and passes exposure to their unborn child. NOWS cases surged from 1.5 per 1,000 hospital births in 2004 to 8 per 1,000 in 2014. Symptoms of NOWS in newborns range from mild and temporary to …

FYR Diagnostics, Texas A&M University, and University of New Mexico awarded NIH grant for early detection of Neonatal Opioid Withdrawal Syndrome (NOWS) Read More »

Medicover partners with FYR Diagnostics to expand into North America and enable additional Precision Medicine services offerings

MISSOULA, Mont., August 17, 2022 – Medicover and FYR Diagnostics (FYR) are proud to announce a new partnership focused on diagnostic test development and Precision Medicine. Through their combined expertise, the collaboration will support pharmaceutical companies with clinical trial assay development and implementation, co-development of novel diagnostic technologies, and companion diagnostic testing services. The companies …

Medicover partners with FYR Diagnostics to expand into North America and enable additional Precision Medicine services offerings Read More »

FYR Diagnostics COVID-19 Variant Update – February 3, 2022

FYR Diagnostics COVID-19 Variant Update – February 3, 2022 Updates are crafted by Katie Havranek PhD, Vik Ghai PhD, Chris Booth PhD, David Booth, Claire Seibold, Tre Blohm, and other team members at FYR Diagnostics. Contents: FYR Pandemic Response Team Updates – Archive Omicron Summary Updates on PCR and rapid antigen testing for SARS-CoV-2 Are …

FYR Diagnostics COVID-19 Variant Update – February 3, 2022 Read More »

FYR Diagnostics Omicron (B.1.1.529) Update – January 7, 2022

Updates are crafted by Chris Booth PhD, Katie Havranek PhD, Vik Ghai PhD, David Booth, Claire Seibold, Tre Blohm, and other team members at FYR Diagnostics. Contents: FYR Pandemic Response Team Updates Summary Where is Omicron (B.1.1.529)? Has Omicron been detected in Montana? Updates about current PCR and antigen testing of Omicron Updates about vaccine …

FYR Diagnostics Omicron (B.1.1.529) Update – January 7, 2022 Read More »

FYR Diagnostics Initiates COVID-19 Variant Tracking in Montana

Missoula company is the state’s first private lab to robustly and efficiently track the spread of variants using targeted RT-PCR technology FYR Diagnostics, a Missoula-based biotech company, is now helping track the growing number of COVID-19 variants that are present in Montana, some of which are believed to be more transmissible and lethal. Select positive …

FYR Diagnostics Initiates COVID-19 Variant Tracking in Montana Read More »

FYR Diagnostics Announces New Large-Scale COVID-19 Test Processing Capability for Montana

High-Throughput Lab with Automation Infrastructure will Increase COVID-19 Testing Availability Missoula, MT – 10/7/20 – FYR Diagnostics, a Missoula- based biotechnology company announced that it will immediately begin processing COVID-19 tests to help increase Montana’s overall testing capacity. FYR will use a test that was developed by the Centers for Disease Control and is authorized …

FYR Diagnostics Announces New Large-Scale COVID-19 Test Processing Capability for Montana Read More »

With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks

Originally posted by GenomeWeb. May 26, 2020 | Kelsy Ketchum, Editor, GenomeWeb — NEW YORK – Ensuring adequate access to testing has been a key hurdle during the COVID-19 pandemic, with test and supply shortages causing roadblocks and capacity not being met. But a new test in the works from Missoula, Montana-based FYR Diagnostics could be …

With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks Read More »

Scroll to Top